Last reviewed · How we verify

NCT04952636

A Prospective Comparative Study of Arthroscopic and Open Surgery in Cuistow Procedure

Status unknown NA Last updated 9 December 2021
What this trial tests

NA trial testing arthroscopic Cuistow in Shoulder Dislocation in 70 participants. Status unknown.

Timeline
6 November 2021
Primary endpoint
30 December 2022
30 December 2023

Quick facts

Lead sponsorPeking University Third Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment70
Start date6 November 2021
Primary completion30 December 2022
Estimated completion30 December 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Eligibility, any sex, with Shoulder Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the clinical outcomes of arthroscopic and open Chinese Unique Inlay Bristow procedure in treating recurrent anterior shoulder instability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Shoulder Dislocation

Currently open trials in the same condition.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04952636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing